By Katie Sorensen, NP-C | Weight Loss NP

Obesity treatment is rapidly changing. With the success of medications like Zepbound (tirzepatide) and Wegovy (semaglutide), many employees are now asking whether their employer health plan covers these highly effective weight loss treatments.

The challenge is that many insurance plans still do not cover medications for obesity.

What Is Lilly Employer Connect?

To address this growing gap, Eli Lilly recently launched a new program called Lilly Employer Connect. This initiative is designed to help employers provide access to GLP-1 medications in a more predictable and affordable way.

For employers and employees alike, this could significantly expand access to evidence-based obesity treatment.

At Weight Loss NP, we believe this model could be an important step toward improving access to care while helping employers manage healthcare costs and workforce health.

In this article we will explain:

• What the Lilly Employer Connect program is
• Who the program is designed for
• Why employers should consider it
• How medical providers like Weight Loss NP can help employees succeed on treatment and keep their results longterm.

---

What Is Lilly Employer Connect?

Lilly Employer Connect is a platform that allows employers to offer coverage for obesity medications such as Zepbound (tirzepatide) through specialized benefit programs outside traditional insurance structures.

The program connects employers with a network of independent program administrators, telehealth providers, and pharmacy partners that help design customized obesity treatment benefits for employees.

Instead of relying entirely on traditional insurance coverage, employers can create their own model for access.

Key features include:

• Access to Zepbound at a discounted acquisition cost of about $449 per month through network pharmacies
• Multiple benefit design options to fit employer budgets
• Partnerships with over 15 healthcare and digital health companies that provide care management and medication access
• Flexible cost sharing between employer and employee (employers can choose how much of the $449/month cost they want to pick up vs pass on to the employee).

The goal is to close the gap between employee demand and insurance coverage for obesity treatment.

Today, roughly half of commercially insured Americans still do not have coverage for weight loss medications, even when medically appropriate.

---

Why Lilly Is Targeting Employers

Obesity affects more than 100 million adults in the United States and is associated with significant healthcare costs and productivity losses.

In fact, obesity is estimated to cost the U.S. economy over $1.7 trillion annually through medical expenses and lost productivity.

Employers are increasingly aware of the impact obesity has on:

• healthcare spending
• employee absenteeism
• disability claims
• workplace productivity

At the same time, employees are increasingly requesting access to GLP-1 medications, which have been shown to produce significant weight loss and improve metabolic health.

The problem is cost.

Traditional insurance plans often exclude obesity medications or restrict access through complex authorization requirements.

Lilly Employer Connect is designed to give employers more control, cost transparency, and flexibility when deciding how to provide this benefit.

---

Which Employers Could Benefit From This Program?

The Lilly Employer Connect model may be particularly attractive to:

Mid-size and large employers

Companies with self-funded or flexible benefit plans may be able to design cost-effective programs that improve employee health while managing risk.

Employers with rising healthcare costs

Chronic conditions linked to obesity include:

• Type 2 diabetes
• heart disease
• sleep apnea
• joint disease

Effective obesity treatment may reduce long-term healthcare costs tied to these conditions.

Companies focused on employee wellness and retention

Offering modern obesity care signals that a company values employee health and evidence-based treatment.

This can improve:

• recruitment
• retention
• employee satisfaction

---

What Employers Should Consider Before Implementing GLP-1 Coverage

While GLP-1 medications are powerful tools, successful programs require thoughtful design.

Employers considering Lilly Employer Connect should evaluate several factors.

1. Clinical oversight matters

GLP-1 medications are not simply weight loss drugs. They are treatments for a chronic metabolic disease.

Proper patient selection, monitoring, and long-term support are critical.

Without medical oversight, programs may see:

• poor adherence
• medication discontinuation
• avoidable side effects

Avoidable side effects impact work productivity and absenteeism, so it is very important to have a knowledgeable and experienced prescriber working with employees to optimize this variable.

2. Lifestyle support improves outcomes

Medication alone is rarely enough.

Successful weight loss programs also include:

• nutrition guidance
• exercise strategies
• behavioral support
• metabolic health monitoring

These elements significantly improve long-term success.

3. Cost management strategies

Employers should consider:

• eligibility criteria
• outcome tracking
• phased rollout programs
• coordinated care management with preferred prescribers, like Weight Loss NP

Well-structured programs can help control costs while maximizing health benefits.

---

Why Medical Partners Matter in Employer GLP-1 Programs

Programs like Lilly Employer Connect provide medication access. However, the clinical care model surrounding the medication is what determines patient success.

That is where experienced obesity medicine providers play a critical role.

A high-quality medical partner can help employers ensure that employees:

• receive appropriate evaluation
• use medications safely
• stay on treatment long enough to benefit
• build sustainable lifestyle changes

Without this clinical structure, many patients discontinue therapy early or struggle to maintain results.

---

Why Weight Loss NP Is an Ideal Partner for Employer Programs

Weight Loss NP specializes in evidence-based medical weight management and metabolic health.

Our practice was built around the idea that obesity treatment should combine medical therapy with long-term behavioral support.

For employers participating in programs like Lilly Employer Connect, Weight Loss NP offers:

Expert GLP-1 medication management

Our clinicians have extensive experience prescribing and monitoring medications such as:

• Mounjaro, Zepbound, (tirzepatide)
• Wegovy, Ozempic (semaglutide)
• other metabolic and adjunctive therapies

Comprehensive lifestyle support

Employees receive guidance on:

• nutrition
• physical activity
• sustainable weight loss habits
• metabolic health optimization

Personalized care

Every patient receives individualized care rather than a one-size-fits-all protocol.

Scalable telehealth care

Weight Loss NP provides care across multiple states with telehealth, allowing employers to support distributed workforces.

Proven patient support systems

Our programs emphasize accountability, motivation, and long-term success, making your investment in your employees health pay off.

---

The Future of Employer-Sponsored Obesity Care

Programs like Lilly Employer Connect represent a shift in how obesity treatment may be delivered in the future.

Instead of relying solely on insurance coverage decisions, employers now have the opportunity to directly offer access to effective therapies.

This approach may lead to:

• greater treatment access
• more predictable employer costs
• improved employee health outcomes

As obesity treatment continues to evolve, partnerships between employers, medication manufacturers, and experienced medical providers will be essential.

---

Final Thoughts

Obesity is a chronic medical condition that affects millions of Americans and drives significant healthcare costs for employers.

Innovations like Lilly Employer Connect could help close the gap between employee demand and treatment access.

However, medication access alone is not enough.

Successful programs require expert medical oversight, lifestyle support, and long-term patient engagement.

That is where providers like Weight Loss NP can make a meaningful difference for both employees and employers.

If your organization is exploring GLP-1 coverage or employer obesity treatment programs, our team would be happy to discuss how we can help support your workforce. Reach out to our founder, Katie Sorensen, NP-C if you’d like more information in participating in this exciting new program and improving the health of your workforce!

Frequently Asked Questions About Lilly Employer Connect and GLP-1 Weight Loss Coverage